OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preserving equipoise and performing randomised trials for COVID-19 social distancing interventions
Ioana A. Cristea, Florian Naudet, John P. A. Ioannidis
Epidemiology and Psychiatric Sciences (2020) Vol. 29
Open Access | Times Cited: 20

Showing 20 citing articles:

Effect estimates of COVID-19 non-pharmaceutical interventions are non-robust and highly model-dependent
V.W.L. Chin, John P. A. Ioannidis, Martin A. Tanner, et al.
Journal of Clinical Epidemiology (2021) Vol. 136, pp. 96-132
Open Access | Times Cited: 59

Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
Perrine Janiaud, Lars G. Hemkens, John P. A. Ioannidis
Canadian Journal of Cardiology (2021) Vol. 37, Iss. 9, pp. 1353-1364
Open Access | Times Cited: 52

Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review
Julian Hirt, Perrine Janiaud, Lars G. Hemkens
BMJ evidence-based medicine (2022) Vol. 27, Iss. 6, pp. 334-344
Open Access | Times Cited: 28

Aggressive measures, rising inequalities, and mass formation during the COVID-19 crisis: An overview and proposed way forward
Michaéla C. Schippers, John P. A. Ioannidis, Ari R. Joffe
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 28

Benefit of COVID-19 vaccination accounting for potential risk compensation
John P. A. Ioannidis
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 37

Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
John P. A. Ioannidis
BMJ Global Health (2021) Vol. 6, Iss. 1, pp. e004614-e004614
Open Access | Times Cited: 34

The effects of public health and social measures (PHSM) implemented during the COVID‐19 pandemic: An overview of systematic reviews
Racha Fadlallah, Fadi El‐Jardali, Lama Bou Karroum, et al.
Cochrane Evidence Synthesis and Methods (2024) Vol. 2, Iss. 5
Open Access | Times Cited: 1

Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models
V.W.L. Chin, John P. A. Ioannidis, Martin A. Tanner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 12

Should COVID-19 vaccination be mandatory?
Juan Víctor Ariel Franco
BMJ evidence-based medicine (2021) Vol. 26, Iss. 6, pp. 269-270
Closed Access | Times Cited: 11

Pandemics, policy, and the power of paradigm: will COVID-19 lead to a new scientific revolution?
Kathleen A. Fairman
Annals of Epidemiology (2022) Vol. 69, pp. 17-23
Open Access | Times Cited: 5

Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
John P. A. Ioannidis
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 6

Aggressive Measures, Rising Inequalities and Mass Formation During the COVID-19 Crisis: An Overview and Proposed Way Forward
Michaéla C. Schippers, John P. A. Ioannidis, Ari R. Joffe
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 4

Authors Response to Letters to the editor regarding: ‘Assessing mandatory stay‐ At‐ Home and business closure effects on the spread of COVID‐ 19’
Eran Bendavid, Christopher Oh, Jay Bhattacharya, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 6
Open Access | Times Cited: 5

Clinical trials during pandemic in primary care: Low number and low validity after one-year experience
Athina Tatsioni, Iliana Siountri, Donatos Tsamoulis, et al.
European Journal of General Practice (2021) Vol. 27, Iss. 1, pp. 274-276
Open Access | Times Cited: 4

The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic
Mariana Barosa, Euzebiusz Jamrozik, Vinay Prasad
Medicine Health Care and Philosophy (2023) Vol. 27, Iss. 1, pp. 49-70
Open Access | Times Cited: 1

COVID-19: A Catalyst for Transforming Randomized Trials
Jennifer Lee, Jerri C. Price, William M. Jackson, et al.
Journal of Neurosurgical Anesthesiology (2021) Vol. 34, Iss. 1, pp. 107-112
Closed Access | Times Cited: 3

Lessons Learned from COVID-19 Trials – Should We Be Doing Clinical Trials Differently?
Perrine Janiaud, Lars G. Hemkens, John P. A. Ioannidis
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 1

Pearls on science, collaboration, and mentorship in health research: A masterclass conversation with Dr. John Ioannidis
Leen Naji, Jeffrey Kay, Isabelle Johansson, et al.
Journal of Clinical Epidemiology (2021) Vol. 139, pp. 235-239
Closed Access | Times Cited: 1

Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis
Julian Hirt, Perrine Janiaud, Lars G. Hemkens
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1

Page 1

Scroll to top